Broad-spectrum cephalosporins were very active against strains of Neisseria meningitidis with both penicillin susceptibility and diminished penicillin susceptibility. Ceftriaxone was the most active antibiotic. Increases in MIC for 90% of meningococci with diminished susceptibility to penicillin of -16-fold were observed for amdinocillin, cefuroxime, aztreonam, and imipenem; 2-fold increases were observed for ceftazidime, mezlocillin, and piperacillin. No differences were observed for non-,-lactam antibiotics.
Penicillin has been the treatment of choice for meningococcal infections for more than 40 years. In contrast to Neisseria gonorrhoeae, until very recently Neisseria meningitidis has conserved its susceptibility to penicillin. Both P-lactamase-producing and non-p-lactamase-producing penicillin-resistant N. meningitidis strains have been isolated (1, 3, 5, 7, 9) . Although isolation of strains with enzymatic resistance is still exceptional, non-p-lactamase-producing strains of meningococci for which benzylpenicillin MICs are 20.25 ,ug/ml (meningococci with diminished susceptibility to penicillin [MDSP] ) are becoming increasingly common in some geographic zones (5) . To study possible therapeutic alternatives and to better comprehend the mechanisms of this resistance, we thought it would be interesting to compare the susceptibilities in vitro of a group of penicillinsusceptible meningococci (MS) (n = 40; 1 All strains were susceptible to chloramphenicol ( Table 1) . The most active agent of those tested was ceftriaxone, with an MIC for all strains of .0.008 p.g/ml. In general, the broad-spectrum cephalosporins showed very good activity, which should be emphasized since broad-spectrum cephalosporins, cefotaxime and ceftriaxone, are the firmest candidates for drugs of choice in the empirical treatment of bacterial meningitis in the near future. The in vitro activities of the antibiotics used in the chemoprophylaxis of meningococcal infection-sulfadiazine, rifampin, ciprofloxacin, and tetracycline (minocycline)-were similar for MS and MDSP; the strains exhibited the typical patterns of susceptibility of strains isolated in Spain (resistance to sulfadiazine and susceptibility to the other three agents) (8) . There was a slightly greater frequency of strains resistant to sulfadiazine and rifampin among MDSP. The differences in the susceptibilities of MS and MDSP were more marked for the 1-lactam antibiotics, especially amdinocillin (mecillinam), cefuroxime, aztreonam, and imipenem; as with penicillin, MDSP were 5 to 50 times more resistant in vitro to these agents than were MS.
Amdinocillin and other 3-lactam antibiotics of dubious indication in the therapy of meningococcal infections were included in the study to examine the effect of the mechanisms of resistance of MDSP on these agents. The MICs of amdinocillin, cefuroxime, aztreonam, and imipenem for 90% of MDSP were -16-fold greater than those for MS; the ceftazidime, mezlocillin, and piperacillin MICs for 90% of strains were barely 2-fold greater. Once the possibility of antibiotic destruction by ,B-lactamase is excluded, the mechanism involved in MDSP resistance could be a penicillinbinding protein (PBP) alteration that impairs antibiotic affinity and/or a reduced permeability of the outer membrane. Recently, a decreased affinity for benzylpenicillin was described in an -59-kilodalton PBP in six MDSP (4). This 
